What is ARS Pharmaceuticals, Inc.'s price / earnings?

ARS Pharmaceuticals, Inc. (SPRY) reported price / earnings of 128.2× in Q4 2024.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

ARS Pharmaceuticals, Inc. SPRY Price / earnings

Price / earnings at other companies

Amneal Pharmaceuticals, Inc.AMRX

32.5×—

ViatrisVTRS

6.5×-6.4×

AMP

Amphastar PharmaceuticalsAMPH

11.2×+1.5×

Catalyst PharmaceuticalCPRX

13.7×-1.3×

Eton Pharmaceuticals, Inc.ETON

105.5×—

Other financials

Income statement

See full

Revenue$22.7M+184%

Operating income-$60.1M-61.8%

Net income-$60.6M-78.6%

EPS (diluted)-$0.61-74.3%

Balance sheet

See full

Cash & equivalents$24.3M-39.0%

Total debt$96.5M+132,122%

Total equity$61.3M-73.2%

Total assets$287.6M-12.1%

Cash flow

See full

Operating cash flow-$44.9M-10.3%

CapEx--100%

Free cash flow-$44.9M-10.1%

Valuation

See full

Market cap$1.05B-32.6%

Enterprise value$1.12B-26.0%

P/S10.6×-5.4×

Profitability

See full

Operating margin-204.5%—

Net margin-200%-219pp

FCF margin-177.1%-206pp

Returns & leverage

See full

Return on equity-136.4%-144pp

Debt / equity1.6×+1.6×

Current ratio4.9×-6.1×

Where this comes from

Calculated from ARS Pharmaceuticals, Inc.’s reported figures.

market cap/net income=128.2×

Based on the most recent quarter.

The official record: ARS Pharmaceuticals, Inc.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s price / earnings?: ARS Pharmaceuticals, Inc. (SPRY) reported price / earnings of 128.2× in Q4 2024.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.